AR035273A1 - Pramipexol para el tratamiento del adhd - Google Patents

Pramipexol para el tratamiento del adhd

Info

Publication number
AR035273A1
AR035273A1 ARP020102946A ARP020102946A AR035273A1 AR 035273 A1 AR035273 A1 AR 035273A1 AR P020102946 A ARP020102946 A AR P020102946A AR P020102946 A ARP020102946 A AR P020102946A AR 035273 A1 AR035273 A1 AR 035273A1
Authority
AR
Argentina
Prior art keywords
adhd
treatment
pramipexol
tetrahyde
pilamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
ARP020102946A
Other languages
English (en)
Spanish (es)
Inventor
Jurgen Reess
Franco Borsini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of AR035273A1 publication Critical patent/AR035273A1/es
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP020102946A 2001-08-03 2002-08-02 Pramipexol para el tratamiento del adhd Withdrawn AR035273A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10137633A DE10137633A1 (de) 2001-08-03 2001-08-03 Pramipexol zur Behandlung von ADHD

Publications (1)

Publication Number Publication Date
AR035273A1 true AR035273A1 (es) 2004-05-05

Family

ID=7693957

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102946A Withdrawn AR035273A1 (es) 2001-08-03 2002-08-02 Pramipexol para el tratamiento del adhd

Country Status (8)

Country Link
EP (1) EP1416930A1 (fr)
JP (1) JP2005500368A (fr)
AR (1) AR035273A1 (fr)
CA (1) CA2453485A1 (fr)
DE (1) DE10137633A1 (fr)
MX (1) MXPA04001001A (fr)
UY (1) UY27408A1 (fr)
WO (1) WO2003013520A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200906997A1 (tr) 2009-09-11 2011-03-21 Sanovel �La� San. Ve T�C. A. �. Pramipeksol farmasötik bileşimleri.
TR200907554A1 (tr) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5621133A (en) * 1989-05-31 1997-04-15 Deninno; Michael P. Dopamine agonists
AU2001261694A1 (en) * 2000-05-19 2001-12-03 Wayne State University Derivatives of 2-aminotetralins and pharmaceutical analogs thereof exhibiting differential cns receptor activity and behavior
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system

Also Published As

Publication number Publication date
CA2453485A1 (fr) 2003-02-20
DE10137633A1 (de) 2003-02-20
EP1416930A1 (fr) 2004-05-12
WO2003013520A1 (fr) 2003-02-20
JP2005500368A (ja) 2005-01-06
UY27408A1 (es) 2003-02-28
MXPA04001001A (es) 2004-04-20

Similar Documents

Publication Publication Date Title
CR7261A (es) Derivados de diarilcicloalquilo, procedimiento para su preparacion y su utilizacion como agentes activadores del ppar
UY28034A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparacion asi como su empleo como medicamentos
UY28040A1 (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos.
ECSP088593A (es) 5-(arilsulfonil)-pirazolopiperidinas
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
SV2003001107A (es) Imidazotriazinas ref.lea 35368
MXPA06013039A (es) El tratamiento de enfermedad respiratoria.
AR037109A1 (es) Uso de flibanserina
SV2002000169A (es) Nuevos derivados del acido aminodicarboxilico con propiedades farmaceuticas ref. lea 33878-sv
UY29437A1 (es) Nuevos antagonistas de cgrp
IL175762A0 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
AR002043A1 (es) Utilizacion de agonistas de alfa (1l) para el tratamiento de la incontinencia urinaria.
DK1162982T3 (da) Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning
SE0400043D0 (sv) New compounds
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
AR055011A1 (es) Compuesto de tetrahidroquinolina, proceso de preparacion del compuesto y su uso para la preparacion de un farmaco
GT200800066A (es) Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento.
AR035273A1 (es) Pramipexol para el tratamiento del adhd
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
AR028970A1 (es) USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE
BRPI0414527A (pt) tratamento de tumores estromáticos gastrointestinais com imatinib e midostaurina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal